Data Sources and Biobanks in the Asia-Pacific Region. Wei Zhou, MD, Ph.D. Department of Epidemiology, Merck Research Laboratories October 23, 2014
|
|
- Kelley Henderson
- 6 years ago
- Views:
Transcription
1 Data Sources and Biobanks in the Asia-Pacific Region Wei Zhou, MD, Ph.D. Department of Epidemiology, Merck Research Laboratories October 23,
2 Disclosures Wei Zhou is currently an employee of Merck and Co., and owns company s stocks The views expressed in this presentation are my personal views and do not necessarily represent the views of Merck 2
3 Goal of this Presentation The goal of this presentation/course is to provide a general introduction of databases/biobanks in the Asia-Pacific region The presentation is not aim to provide a comprehensive list of the Asia databases or biobanks 3
4 Presentation Outline Why are we interested in Asia data sources and biobank? What are the available Asia data sources and biobank? How to address the challenges in collaborating and accessing Asia data sources and biobank? Question and Discussion 4
5 Why are we interested in Asia data sources and biobank? Asia population and Western population are different Genetic background Standard of care and heath care system setting Economy and access to health care Life style and diet Other risk factors including environmental exposure 5
6 Genetic Differences between Asian and Western Populations Genetic polymorphism and response to treatment IL-28 polymorphism and response to SOC among HCV patients Somatic mutations and response to treatment EGFR mutation and response to EGFR-TKI among NSCLC patients 6
7 IL-28B and HCV Treatment CC homozygous genotype is associated with ~ 2-fold increase in the probability of response to therapy; may respond to shorter durations of therapy ; The rs C variant is most frequently present in individuals from East Asia (allele frequency >0.9) Ge D.et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature Sep 17;461(7262):
8 EGFR Mutation and Copy Number in NSCLC Shigematsu and Gazdar, Int J Cancer, 2006;118:257 EGFR copy numbers and survival of NSCLC patients (Dahabreh et al., Ann Onc, 2010; Advance Publication) 8
9 SOC Differences between Asian and Western Populations The health care system may be different between Asia and western countries Big hospitals vs. community hospitals/primary physician Economy development Access to innovative drug and vaccines Insurance and affordability 9
10 Other Differences between Asian and Western Populations Life style Diet Culture Environmental and occupational exposure including smoking 10
11 Asian Populations are Heterogeneous What are the Asian Populations East Asia: Chinese (China mainland, Taiwan, Hong Kong), Japanese, Korean India South Eastern Asia: Vietnamese, Philippines, Singapore Middle East Others Asian are also heterogenous for the following Genetic background Standard of care and heath care system setting Economy and access to health care Life style and diet Other risk factors including environmental exposure 11
12 Genetic heterogeneous among Asian Populations In a study on the variation of five polymorphic loci on the Y chromosome from 1,260 males in eight ethnic groups of East Asia (Kim et al., J Hum Genet, 2000;45:76) In another study of 11 Y chromosome short tandem repeat (Y-STR) loci in 700 males from ten ethnic groups in East Asia (Kwak et al., Int J Legal Med, 2005;119:195) In a study on mitochondrial DNA (mtdna) sequence variation in the hypervariable segments I and II and haplogroup-specific mutations in coding regions in 445 individuals from seven East Asian populations (Jin et al., PLOS One, 2009;4:e4210 Ref: left Fig, Kwak et al., Int J Legal Med, 2005;119:195 Right table: Jin et al., PLOS One, 2009;4:e
13 A recent study employed whole-genome autosomal SNPs (54,836 SNP markers), using 320 subjects covering 24 regional groups including Northern (=16) and Southern (=3) Asians, Amerindians (=1), and four HapMap populations (YRI, CEU, JPT, and CHB) The results suggested that the East Asian group revealed the highest level of differentiation compared to Northern and Southern Asians, whereas there was no difference among East Asians, including Koreans, Japanese and Chinese Jung et al., PLOS One, 2010;5:e
14 Jung et al, PLOS One, 2010;5:e
15 Hormone Status Among Asian Breast Cancer Patients in US Breast Cancer Subtypes in Asians in the California Cancer Registry 1 Luminal A n = 3,957 (%) Luminal B n = 1,209 (%) HER2+/ER- n = 683 (%) All HER2+ n = 1,892 (%) Basal = 788 (%) Japanese 714 (67) 166 (16) 73 (7) 239 (23) 108 (10) Chinese 1143 (62) 317 (17) 169 (9) 486 (26) 207 (11) Filipina 1310 (58) 431 (19) 283 (13) 714 (32) 234 (10) Korean 217 (47) 109 (24) 56 (12) 165 (36) 75 (16) Vietnamese 313 (55) 118 (21) 61 (11) 179 (31) 81 (14) South Asian 260 (58) 68 (15) 41 (9) 109 (24) 83 (18) n Recent Studies suggest that differences in breast cancer subtypes exist among ethnic subgroups of Asian women The difference may be also due to different patient characteristics including age Breast Cancer Subtypes in New York City 2 1 Telli et al 2 McCarville et al Cancer Res 2009;69(24 Suppl):Abstract nr
16 Presentation Outline Why are we interested in Asia data sources and biobank? What are the available Asia data sources and biobank? How to address the challenges in collaborating and accessing Asia data sources and biobank? Question and Discussion 16
17 Asian Databases/biobanks Types of Asian databases/biobanks Consortium National/regional biobank link with EMR databases Individual Cohort Project specific collaboration Hospital based databases/biobanks Databases and biobanks can be further classified into different categories Discovery versus hypothesis driven Funding sources: government, academic/hospital, CRO, pharmaceutical/biotech companies 17
18 Examples of Asian Databases and Biobanks 18
19 AsPEN AsPEN, the Asian Pharmacoepidemiology Network ( A multi-national research network which was formed to provide a mechanism to support the conduct of pharmacoepidemiological research To facilitate the prompt identification and validation of emerging safety issues among the Asian countries Including researchers from Australia, China mainland, Hong Kong, Japan, Korea, Singapore, Sweden, Taiwan, and USA Focus on pharmacoepidemiology research, not linked with genetic information 19
20 Asian Cohort Consortium ACC or Asian Cohort Consortium ( To understand the relationship between genetics, environmental exposures, and the etiology of disease through the establishment of a cohort of at least one million healthy people around the world The consortiums covers populations from China, India, Iran, Japan, Korea, Malaysia, Singapore, Taiwan Most of the cohorts have genetic materials collected There have been several publications out 20
21 International Cancer Genome Consortium ICGC ( Including researchers from China, India, Japan, Saudi Arabia, South Korea, and other places around the world The primary goals are to Generate comprehensive catalogues of genomic abnormalities (somatic mutations, abnormal expression of genes, epigenetic modifications) in tumors from 50 different cancer types and/or subtypes Make the data available to the entire research community as rapidly as possible 21
22 Asian Cancer Research Group (ACRG) Formed in 2010, ACRG is an independent, not-for-profit company established jointly by Eli Lilly, Merck and Pfizer to accelerate research, and ultimately improve, treatment for patients affected with the most commonly-diagnosed cancers in Asia. Asian Cancer Research Group (ACRG) lung stomach liver tumor tissue ACRG seeks to improve the knowledge of cancers prevalent in Asia by generating comprehensive genomic data sets and sharing them freely with the scientific community in order to accelerate drug discovery efforts 22
23 China Kadoorie Biobank China Kadoorie Biobank, or CKB ( CKB is set up to investigate the main genetic and environmental causes of common chronic diseases in the Chinese population During , over 510,000 adults were recruited from 10 geographically defined regions of China, with extensive data collection by questionnaire and physical measurements, and with long-term storage of blood samples for future study Every few years, periodic re-surveys are also to be conducted in about 25,000 surviving participants, with a repeat interview, measurements and blood collection (as in the baseline survey) to help assess changes of risk exposures in the study population There have been lots of publications out 23
24 Korea Biobank Project Korea Biobank Project, or KBP, is a network between the National Biobank of Korea and biobanks run by universityaffiliated general hospitals (regional biobanks) The first phase of KBP aims to collect human biospecimens from 500,000 participants (including 300,000 populationbased participants and 200,000 disease-based participants) with their epidemiological and clinical information until 2012 As of December-2011, the NBK has collected human biospecimens from 525,416 participants including 325,952 Korean populations and 199,464 patients (serum, plasma, DNA, and others) The second phase started in 2013, with the goal to support projects by 2015 Lee et al., Osong Public Health Res Perspect. 2012; 3(3):
25 The BioBank Japan Project The Biobank Japan Project ( was started in 2003 and end in 2012 Aim to investigate the relationships between SNP in approximately 300,000 people and the efficacy and side effect of drugs Achievements - Number of acquired ICs: 201,805 persons; Total number of analyzed diseases: 287,919 (up to February 2008) 25
26 Presentation Outline Why are we interested in Asia data sources and biobank? What are the available Asia data sources and biobank? How to address the challenges in collaborating and accessing Asia data sources and biobank? Question and Discussion 26
27 Challenges of Accessing Asia Databases Awareness and understand the importance of international collaboration Funding sources Ethnic, legal, and social impact Informed consent, privacy, data protection Restriction of sample and data export Data sharing Link genetic/genomic information with medical records Personnel expertise 27
28 How to Address the Challenges? Law and regulations Encourage the collaboration (international and internal collaboration) Data sharing, publication, and accessing Education 28
29 Presentation Outline Why are we interested in Asia data sources and biobank? What are the available Asia data sources and biobank? How to address the challenges in collaborating and accessing Asia data sources and biobank? Question and Discussion 29
30 Question #1 Question: Are Asian populations same or different? Answer: 1) Same. We have similar genetic background and similar culture 2) Different. They are genetically similar, however, the culture, life style, and health care settings are different 3) Different. Although the culture and life styles are similar, the Asian populations have different genetic background 4) Different: Asian Populations may have different genetic background, as well as culture, life style, or health care setting differences 30
31 Question #2 Question: what are the major challenges in Asia databases/biobank research? Answer: 1) Funding and budget 2) Regulation and ethnic 3) Restriction of sample and data export 4) All of them 31
32 Other Questions 32
Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC
Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results
More informationDNA Studies (Genetic Studies) Disclosure Statement. Definition of Genomics. Outline. Immediate Present and Near Future
Advances in Genetic Marker Evaluation Prior to Vascular Access Creation Timmy Lee, M.D., M.S.P.H., F.A.C.P., F.A.S.N. Assistant Professor of Medicine Division of Nephrology and Hypertension University
More informationASIA PACIFIC ADVERTISING TRENDS
ASIA PACIFIC ADVERTISING TRENDS April 2017 Table of Contents Executive Summary 1-24 Sources And Methodology 3 Overview 4-8 Asia Pacific Advertising Revenue (US$ mil.) 5 Asia Pacific Advertising Market
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationSupplementary Figure 1. Study design of a multi-stage GWAS of gout.
Supplementary Figure 1. Study design of a multi-stage GWAS of gout. Supplementary Figure 2. Plot of the first two principal components from the analysis of the genome-wide study (after QC) combined with
More informationGhazalaRubi. F.I.B.M.S; MPhil(Mol.Bio) PhD (Human Genetics & Mol.Bio)
GhazalaRubi B.Sc, M.Sc, F.I.B.M.S; MPhil(Mol.Bio) PhD (Human Genetics & Mol.Bio) Personal Detail Personal Information Name : Ghazala Rubi email rubighazala@yahoo.com Nationality : Pakistani Place of Birth
More informationBlood Pressure and Hypertension Genetics
Blood Pressure and Hypertension Genetics Yong Huo, M.D. Wei Gao, M.D. Yan Zhang, M.D. Santhi K. Ganesh, M.D. Outline Blood pressure and hypertension in China Update on genetics of blood pressure BP/HTN
More informationASIA PACIFIC ADVERTISING TRENDS
ASIA PACIFIC ADVERTISING TRENDS March 2018 Executive Summary 1-50 Regional Summary 5-6 Sources And Methodology 7 Regional Overview 8-15 Net Advertising In Asia Pacific 8 Advertising Y/Y Growth By Segment
More informationAsia A New Frontier for Clinical Research and Development
Asia A New Frontier for Clinical Research and Development Executive Summary As the pharmaceutical market experiences rapid growth in Asia, more clinical trials are being conducted in the region, offering
More informationStatistical Tools for Predicting Ancestry from Genetic Data
Statistical Tools for Predicting Ancestry from Genetic Data Timothy Thornton Department of Biostatistics University of Washington March 1, 2015 1 / 33 Basic Genetic Terminology A gene is the most fundamental
More informationGenetic Variation and Genome- Wide Association Studies. Keyan Salari, MD/PhD Candidate Department of Genetics
Genetic Variation and Genome- Wide Association Studies Keyan Salari, MD/PhD Candidate Department of Genetics How many of you did the readings before class? A. Yes, of course! B. Started, but didn t get
More informationSupplementary Figure 1 a
Supplementary Figure 1 a b GWAS second stage log 10 observed P 0 2 4 6 8 10 12 0 1 2 3 4 log 10 expected P rs3077 (P hetero =0.84) GWAS second stage (BBJ, Japan) First replication (BBJ, Japan) Second replication
More informationFEBRUARY 2015 D. Lee Spurgin, Jr., PhD
FEBRUARY 2015 D. Lee Spurgin, Jr., PhD Resources - Publications Little Advisor ICH-GCP, Investigational Site - English Little Advisor ISO 14155:2011, Sponsor Responsibilities - English Little Advisor ISO
More informationExome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.
Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all
More informationNON-INTERVENTIONAL STUDY ABSTRACT FOR EXTERNAL DISCLOSURE
NON-INTERVENTIONAL STUDY ABSTRACT FOR EXTERNAL DISCLOSURE Title: KIMS (Pfizer International Metabolic Database) Date of Abstract: 25 February 2015 Keywords: Growth hormone deficiency, Genotropin, hypopituitarism.
More informationPersonalized Human Genome Sequencing
Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome
More informationAlgorithms for Genetics: Introduction, and sources of variation
Algorithms for Genetics: Introduction, and sources of variation Scribe: David Dean Instructor: Vineet Bafna 1 Terms Genotype: the genetic makeup of an individual. For example, we may refer to an individual
More informationThe Evolution of Clinical Research in East Asia
The Evolution of Clinical Research in East Asia DORO SHIN, MPH Principal Analyst, Infectious & Genitourinary Diseases Clinical research has become increasingly globalized and a large patient pool of nearly
More informationIntroduction to Genetics and Pharmacogenomics
Introduction to Genetics and Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Survey on pharmacogenomic knowledge Survey
More informationSingle Nucleotide Polymorphisms (SNPs)
Single Nucleotide Polymorphisms (SNPs) Sequence variations Single nucleotide polymorphisms Insertions/deletions Copy number variations (large: >1kb) Variable (short) number tandem repeats Single Nucleotide
More informationLinking Genetic Variation to Important Phenotypes
Linking Genetic Variation to Important Phenotypes BMI/CS 776 www.biostat.wisc.edu/bmi776/ Spring 2018 Anthony Gitter gitter@biostat.wisc.edu These slides, excluding third-party material, are licensed under
More informationThe Whole Genome TagSNP Selection and Transferability Among HapMap Populations. Reedik Magi, Lauris Kaplinski, and Maido Remm
The Whole Genome TagSNP Selection and Transferability Among HapMap Populations Reedik Magi, Lauris Kaplinski, and Maido Remm Pacific Symposium on Biocomputing 11:535-543(2006) THE WHOLE GENOME TAGSNP SELECTION
More informationPharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001
Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response
More informationMolecular Diagnostics at the Point of Need Interim Results (to Dec-17) 20 March 2018
Molecular Diagnostics at the Point of Need Interim Results (to Dec-17) 20 March 2018 2 Decentralising molecular diagnostics DOCUMENT INFORMATION The information contained in this document and made verbally
More informationGenome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Supplementary Materials
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations Supplementary Materials Chen Wu 1, 22, Xiaoping Miao 2, 22, Liming Huang 1,
More informationIOM PM ROUNDTABLE MMRF UPDATE WALTER M. CAPONE CHIEF OPERATING OFFICER MARCH 21, 2012
IOM PM ROUNDTABLE MMRF UPDATE WALTER M. CAPONE CHIEF OPERATING OFFICER MARCH 21, 2012 MMRF MODEL OVERVIEW The MMRF is the largest private funder of multiple myeloma research raising over $190M to-date
More informationUK Biobank Axiom Array
DATA SHEET Advancing human health studies with powerful genotyping technology Array highlights The Applied Biosystems UK Biobank Axiom Array is a powerful array for translational research. Designed using
More informationSingle Nucleotide Variant Analysis. H3ABioNet May 14, 2014
Single Nucleotide Variant Analysis H3ABioNet May 14, 2014 Outline What are SNPs and SNVs? How do we identify them? How do we call them? SAMTools GATK VCF File Format Let s call variants! Single Nucleotide
More informationWhy Culture Matters in Cancer Research
Why Culture Matters in Cancer Research Edward L. Trimble, MD, MPH National Cancer Institute Government-University-Industry Research Roundtable, July 29-31, 2013 Need for international research collaboration
More informationGlobal Development in Asia -a JPMA perspective-
Global Development in Asia -a JPMA perspective- October/13 th /2006 Hironobu Saito Senior Vice Director Asian Drug Development and Registration & Clinical Development Department New Drug Development Division
More informationCORPORATE RESPONSIBILITY TOWARDS ETHICAL RESEARCH
The Asia Pacific Perspective CORPORATE RESPONSIBILITY TOWARDS ETHICAL RESEARCH Aileen Dualan, MD, MS Disclaimer The speaker is an employee of Novartis, a former employee and stockholder at Abbott, Abbvie,
More informationLinking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls
Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls BMI/CS 776 www.biostat.wisc.edu/bmi776/ Colin Dewey cdewey@biostat.wisc.edu Spring 2012 1. Understanding Human Genetic Variation
More informationSupplementary Information. Werner Koch, Petra Hoppmann, Jakob C. Mueller, Albert Schömig & Adnan Kastrati
Supplementary Information Werner Koch, Petra Hoppmann, Jakob C. Mueller, Albert Schömig & Adnan Kastrati The Supplementary Information has the following sections in order: 1. Supplementary Methods 2. Supplementary
More informationPOLYGENIC RISK SCORES FOR RISK ASSESSMENT
POLYGENIC RISK SCORES FOR RISK ASSESSMENT RICHARD KARLSSON LINNÉR EXPERT FORUM ON GENOMIC MEDICINE OCTOBER 23, 2018 # Het begint met een idee INTRODUCTION # Het begint met een idee GENETIC HEALTH RISKS
More informationThe HUNT Study and potential for innovation and industry research collaboration
1 The HUNT Study and potential for innovation and industry research collaboration Professor Kristian Hveem, MD, PhD, Director of HUNT biobank, NTNU Head of Biobank Norway (BBMRI.no) Head of K.G. Jensen
More informationClinical Trial Research in the Precision Medicine Era: the Manchester City Approach
1 Clinical Trial Research in the Precision Medicine Era: the Manchester City Approach JACK LONDON, PHD RESEARCH PROFESSOR OF CANCER BIOLOGY THOMAS JEFFERSON UNIVERSITY DIRECTOR OF INFORMATICS SIDNEY KIMMEL
More information분자 - 유전체역학연구 Molecular and Genome Epidemiologic Study. Dong-Hyun Kim Hallym University College of Medicine
분자 - 유전체역학연구 Molecular and Genome Epidemiologic Study Dong-Hyun Kim Hallym University College of Medicine Evolving epidemiologic study Environmental Exposure (e.g. alcohol/diet)? Who is susceptible? What
More informationThe EORTC Molecular Screening programme SPECTA
The EORTC Molecular Screening programme SPECTA February 2016 Denis Lacombe, MD, MSc EORTC, Director General Brussels, Belgium The changing shape of clinical research Phase I RESOURCES Phase III The changing
More informationProf. Dr. Konstantin Strauch
Genetic Epidemiology and Personalized Medicine Prof. Dr. Konstantin Strauch IBE - Lehrstuhl für Genetische Epidemiologie Ludwig-Maximilians-Universität Institut für Genetische Epidemiologie Helmholtz-Zentrum
More informationPharmacogenetics of Drug-Induced Side Effects
Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA
More informationAssociation studies (Linkage disequilibrium)
Positional cloning: statistical approaches to gene mapping, i.e. locating genes on the genome Linkage analysis Association studies (Linkage disequilibrium) Linkage analysis Uses a genetic marker map (a
More informationGenomic Medicine for the University of Vermont Health Network
Genomic Medicine for the University of Vermont Health Network The heart and science of medicine. Debra G.B. Leonard, M.D., Ph.D. Chair & Professor, Pathology & Laboratory Medicine Robert Larner, M.D. College
More informationNature Genetics: doi: /ng.3143
Supplementary Figure 1 Quantile-quantile plot of the association P values obtained in the discovery sample collection. The two clear outlying SNPs indicated for follow-up assessment are rs6841458 and rs7765379.
More informationNational Health Research Institutes
National Health Research Institutes October 2008 History The founding of the National Health Research Institutes (NHRI) was first proposed in 1988 by members of Academia Sinica. In 1994 a preparatory committee
More informationLeveraging an Academic-Industry Partnership for Commercial Success
Leveraging an Academic-Industry Partnership for Commercial Success For 115 Years, the Nation s Leading Respiratory Hospital Respiratory Heritage: 115 Years of Respiratory Research and Care Allergy, Asthma,
More informationInformation Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008
Information Technology for Genetic and Genomic Based Personalized Medicine Submitted April 23, 2008 By The Harvard Medical School Partners HealthCare Center for Genetics and Genomics in Partnership with
More informationChallenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland
Challenges of Personalized Health for Clinical Medicine Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Personalisierte Medizin Personalisierte Gesundheit Personalisierte
More informationGenetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health
Genetics/Genomics in Public Health Role of Clinical and Biochemical Geneticists in Public Health Premises Human variation is vast Strength of genetic factors are a continuum from low to high Testing technology
More informationAge-Adjusted Death Rates for Coronary Heart Disease, U.S.,
Age-Adjusted Death Rates for Coronary Heart Disease, U.S., 1950-2004 Deaths/100,000 Population 600 500 400 300 200 100 Risk Factors U.S. Actual U.S. "Could Be" (Based on Japan Actual) 0 1950 1960 1970
More informationEPIB 668 Genetic association studies. Aurélie LABBE - Winter 2011
EPIB 668 Genetic association studies Aurélie LABBE - Winter 2011 1 / 71 OUTLINE Linkage vs association Linkage disequilibrium Case control studies Family-based association 2 / 71 RECAP ON GENETIC VARIANTS
More informationWHITE PAPER. establishing a regulatory Drug Development Strategy for Asia Pacific
WHITE PAPER establishing a regulatory Drug Development Strategy for Asia Pacific ppdi.com July 2012 EXECUTIVE SUMMARY As the economic power of China and other Asian countries grows, many biopharmaceutical
More informationAll research lines at the LMU have a strong methodological focus
Content: Genetic Epidemiology and Statistical Genetics in Complex Diseases... 2 Molecular Epidemiology of Complex Phenotypes... 2 Clinical Trials and Translational Medicine... 3 Clinical Epidemiology and
More informationIntroduction to Pharmacogenomics
Introduction to Pharmacogenomics Ching-Lung Cheung, PhD Assistant Professor, Department of Pharmacology and Pharmacy, Centre for Genomic Sciences, HKU Overview of the lecture Overview of the lecture Introduction
More informationMMRF and MMRC. Collaborative Research Model for a Rare Disease. Susan L. Kelley, M.D. MMRF and MMRC 11/23/2009. Collaborative Model
Collaborative Research Model for a Rare Disease Susan L. Kelley, M.D. 1 OVERVIEW Multiple myeloma is an orphan blood cancer with a low 5-year survival rate. African American incidence is twice that of
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationGeneral background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD)
General background text Pharmacogenetics Dihydropyrimidine dehydrogenase (DPD) Last updated: 26 October 2017 Definitions in pharmacogenetics The genotype is the hereditary information about a specific
More informationGenome-wide association study identifies a susceptibility locus for HCVinduced hepatocellular carcinoma. Supplementary Information
Genome-wide association study identifies a susceptibility locus for HCVinduced hepatocellular carcinoma Vinod Kumar 1,2, Naoya Kato 3, Yuji Urabe 1, Atsushi Takahashi 2, Ryosuke Muroyama 3, Naoya Hosono
More informationThe Importance of Feasibility Studies for Oncology Clinical Trials
The Importance of Feasibility Studies for Oncology Clinical Trials www.ppdi.com Executive Summary The segmenting of the oncology patient population has increased the challenges in designing clinical trials.
More informationUp Close and Personal
Special Report Up Close and With Personal advances in genetics, a new type of medicine has emerged: one that s tailored just for you and your DNA. Could it transform the paradigm of how we treat and prevent
More informationProstate Cancer Genetics: Today and tomorrow
Prostate Cancer Genetics: Today and tomorrow Henrik Grönberg Professor Cancer Epidemiology, Deputy Chair Department of Medical Epidemiology and Biostatistics ( MEB) Karolinska Institutet, Stockholm IMPACT-Atanta
More informationIRB USE ONLY Approval Date: September 10, 2013 Expiration Date: September 10, 2014
Approval : September 10, 2013 Expiration : September 10, 2014 DESCRIPTION: You are invited to donate your excess sperm and/or testicular biopsy material, as well as your somatic cells (ordinary body cells
More informationTransform Clinical Research Into Value-Based Personalized Care
SAP Brief PUBLIC SAP Medical Research Insights Transform Clinical Research Into Value-Based Personalized Care SAP Brief Seamlessly combine clinical research with clinical routine Cutting-edge clinical
More informationTHE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( )
THE ERA OF INDIVIDUAL GENOMES Sandra Viz Lasheras Advanced Genetics (2017-2018) CONTENTS 1. INTRODUCTION - The genomic era - Sequencing techniques 2. PROJECTS - 1000 genomes project - Individual genome
More informationPharmacogenomics information in SmPC
Pharmacogenomics information in SmPC SmPC training presentation Note: for full information refer to the European Commission's Guideline on summary of product characteristics (SmPC) SmPC Advisory Group
More informationBioinformatic Analysis of SNP Data for Genetic Association Studies EPI573
Bioinformatic Analysis of SNP Data for Genetic Association Studies EPI573 Mark J. Rieder Department of Genome Sciences mrieder@u.washington washington.edu Epidemiology Studies Cohort Outcome Model to fit/explain
More informationBiomedical Big Data and Precision Medicine
Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationTowards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory
Towards a P4 Healthcare System: Predictive, Preventive, Personalized & Participatory Bull, 2012 Natalia Jiménez Lozano Business Development Manager BULL e-health Consultancy & Business Solutions Tlf: 913939253
More informationGenentech, Inc., its research partners, collaborators, assignees, licensees or designees. Invitation to Participate
CONSENT AND RESEARCH AUTHORIZATION TO DONATE BLOOD AND TISSUE SAMPLES FOR FUTURE RESEARCH PURPOSES YALE UNIVERSITY SCHOOL OF MEDICINE YALE-NEW HAVEN HOSPITAL 200 FR. 4 Study Title: An Open-Label, Phase
More informationAppendix 5: Details of statistical methods in the CRP CHD Genetics Collaboration (CCGC) [posted as supplied by
Appendix 5: Details of statistical methods in the CRP CHD Genetics Collaboration (CCGC) [posted as supplied by author] Statistical methods: All hypothesis tests were conducted using two-sided P-values
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationPharmacogenetics in American Indian Populations
Pharmacogenetics in American Indian Populations Erica L. Woodahl, Ph.D. Associate Professor Department of Biomedical and Pharmaceutical Sciences University of Montana What is Pharmacogenomics? Responders
More informationPopulation differentiation analysis of 54,734 European Americans reveals independent evolution of ADH1B gene in Europe and East Asia
Population differentiation analysis of 54,734 European Americans reveals independent evolution of ADH1B gene in Europe and East Asia Kevin Galinsky Harvard T. H. Chan School of Public Health American Society
More informationUK Biobank Past, Present, and Future
UK Biobank Past, Present, and Future November 2018 Recruitment & Collection Data Access & Enhancement Specification & Definition Study Conceived Development Prospective study of 500,000 people aged 40-69
More informationArto Mannermaa. Research Manager, KUH Professor of personalized medicine and Biobanking, UEF
Doctoral Programme of Clinical Research Introduction to Clinical Research, 2017 Arto Mannermaa Research Manager, KUH Professor of personalized medicine and Biobanking, UEF 040-3552752 arto.mannermaa@uef.fi
More informationISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1
Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical
More informationLinking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls
Linking Genetic Variation to Important Phenotypes: SNPs, CNVs, GWAS, and eqtls BMI/CS 776 www.biostat.wisc.edu/bmi776/ Mark Craven craven@biostat.wisc.edu Spring 2011 1. Understanding Human Genetic Variation!
More informationGenotype Prediction with SVMs
Genotype Prediction with SVMs Nicholas Johnson December 12, 2008 1 Summary A tuned SVM appears competitive with the FastPhase HMM (Stephens and Scheet, 2006), which is the current state of the art in genotype
More informationPHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14
PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped
More informationMultiple Sclerosis Treatment Market Research Report - Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/940 Multiple Sclerosis Treatment Market Research Report - Global Forecast till 2023 Report / Search Code: MRFR/HC/0434-HCRR
More informationComparative Effectiveness Research and Personalized Medicine: Policy, Science and Business. Setting the Stage. October 28, 2009 Washington, DC
Comparative Effectiveness Research and Personalized Medicine: Policy, Science and Business Setting the Stage October 28, 2009 Washington, DC Clifford Goodman, PhD Vice President clifford.goodman@lewin.com
More informationSolutions will be posted on the web.
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel NAME TA SEC 7.012 Problem Set 7 FRIDAY December 3,
More informationSupplementary Note: Detecting population structure in rare variant data
Supplementary Note: Detecting population structure in rare variant data Inferring ancestry from genetic data is a common problem in both population and medical genetic studies, and many methods exist to
More informationProposed Recommendations of the European Society of Human Genetics
Genetic Testing and Common Disorders Proposed Recommendations of the European Society of Human Genetics DRAFT version 18 May 2009, PLEASE DO NOT QUOTE Introductory considerations After the focus on monogenic
More informationWalk Through The Y Project. FTDNA Conference 2010 Houston TX Dipl.- Ing. Thomas Krahn
Walk Through The Y Project FTDNA Conference 2010 Houston TX Dipl.- Ing. Thomas Krahn Participants - Origin Austria 1 Basque 2 Belarus 2 Belgium 2 Czech Republic 1 Egypt 1 Finland 3 France 7 Georgia 3 Germany
More informationFirst Annual Biomarker Symposium Quest Diagnostics Clinical Trials
First Annual Biomarker Symposium Quest Diagnostics Clinical Trials Terry Robins, Ph.D. Director Biomarker R&D and Scientific Affairs Quest Diagnostics Clinical Trials Key Considerations: Biomarker Development
More informationPerformance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen
1 // Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen ABSTRACT Here we describe the analytical performance of the newly developed non-invasive prenatal multi-gene
More informationQuo vadis Medical Industry?
Quo vadis Medical Industry? 17th December 2015 Karl Branzén Sweden has experienced the winds of change in the drug industry u In the 70s and 80s Sweden had two big medical/drug corporations Pharmacia and
More informationFamilial Breast Cancer
Familial Breast Cancer SEARCHING THE GENES Samuel J. Haryono 1 Issues in HSBOC Spectrum of mutation testing in familial breast cancer Variant of BRCA vs mutation of BRCA Clinical guideline and management
More information1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and
1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and Development Market in Asia - Overview 3.1 Introduction 3.1.1
More informationIntegrating pharmacogenetics into national formularies: setting an international research agenda. Dr Howard L McLeod
Integrating pharmacogenetics into national formularies: setting an international research agenda Dr Howard L McLeod Professor of Medicine, Genetics, and Pharmacology Washington University, St Louis, USA
More informationRegulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ
Regulatory Challenges of Global Drug Development in Oncology Jurij Petrin, M.D. Princeton, NJ Topics General global R&D issues Regulatory issues with global oncology drug development US FDA initiatives
More informationTHE WHITE HOUSE Office of the Vice President
FOR IMMEDIATE RELEASE October 17, 2016 THE WHITE HOUSE Office of the Vice President FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance
More informationGenetic Identification of Ancient Korean Remains
Genetic Identification of Ancient Korean Remains Kyoung-Jin Shin, D.D.S., Ph.D. Department of Forensic Medicine Yonsei University College of Medicine, Seoul, Korea Merits and difficulties of ancient DNA
More informationCancer survival trends and inequalities: what is the role for Europe?
Cancer survival trends and inequalities: what is the role for Europe? European Joint Action on Comprehensive Cancer Control 2014-2017 Brussels, Belgium, 13 May 2015 Measures of cancer burden definition
More informationTranslational Medicine in the Era of Big Data: Hype or Real?
Translational Medicine in the Era of Big Data: Hype or Real? AAHCI MENA Regional Conference September 27, 2018 AKL FAHED, MD, MPH @aklfahed Disclosures None 2 Outline The Promise of Big Data Genomics Polygenic
More informationSNPs - GWAS - eqtls. Sebastian Schmeier
SNPs - GWAS - eqtls s.schmeier@gmail.com http://sschmeier.github.io/bioinf-workshop/ 17.08.2015 Overview Single nucleotide polymorphism (refresh) SNPs effect on genes (refresh) Genome-wide association
More informationWu et al., Determination of genetic identity in therapeutic chimeric states. We used two approaches for identifying potentially suitable deletion loci
SUPPLEMENTARY METHODS AND DATA General strategy for identifying deletion loci We used two approaches for identifying potentially suitable deletion loci for PDP-FISH analysis. In the first approach, we
More informationMoving from volume to value in the generic business model
Moving from volume to value in the generic business model CPhI Pre-connect conference Frankfurt 23rd October 2017 Copyright 2016 QuintilesIMS. All rights reserved. Key drivers to 2021 Global growth moderating
More informationSupplementary Figure 1 Genetic relationship between local Tibetans and other East Asian populations.
Supplementary Figure 1 Genetic relationship between local Tibetans and other East Asian populations. 1 (A) Principal-components analysis. The first two principal components (PCs) are shown. Each individual
More information